Requiring price disclosures on advertisements for prescription drugs would empower patients and reduce excess spending on ...

Foolish and ethically compromised senators will expose themselves to ridicule and possible electoral banishment by opposing ...

Kennedy seeks to be Secretary of Health and Human Services — a position that would put him in charge of the health of the ...

President Donald Trump's nominee for health secretary, Robert F. Kennedy Jr.'s nomination hearings began Wednesday before the ...

How has the relationship between Big Pharma and biotech evolved? And where do CROs fit into the mix? Dearth of VC funding forcing difficult biotech decisions The realities of the global economy ...

On January 20, a new administration began addressing our nation’s pressing problems, including health care costs. Drug costs ...

With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.

Neomorph is building out its supply of Big Pharma partnerships, this time stamping down an option-to-license pact with AbbVie that centers around the biotech’s molecular glue platform. | Neomorph is ...